Ticker League

Tango Therapeutics (TNGX) Profit Bridge

See what drove Tango Therapeutics's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

+39.04%

Operating Income YoY

+19.43%

Net Income YoY

+18.90%

Net Margin Δ

+13447 bps

Net income bridge for Tango Therapeutics (TNGX) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $25.03M+18.90%

Profit bridge breakdown for Tango Therapeutics (TNGX) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income−$132.26M
  • Revenue$16.00M
  • Cost of Revenue−$1.57M
  • Operating Expenses$13.91M
  • Other Income / Expense−$3.54M
  • Income Tax$231.00K
  • Net Loss−$107.23M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation